CCL5, C-C motif chemokine ligand 5, 6352

N. diseases: 514; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0702166
Disease: Acne
Acne
0.010 AlteredExpression disease BEFREE As part of the SICS, this study was conducted to evaluate the association between the incidence of acne vulgaris in SM-exposed subjects (20 years after the exposure) and serum levels of proinflammatory cytokines (IL-1α, IL-1β, IL-1Ra, IL-6, IL-8, IL-12 and RANTES) in an attempt to better understand the pathogenesis of long-term skin disorders of these individuals. 28193081 2017
CUI: C0001144
Disease: Acne Vulgaris
Acne Vulgaris
0.010 AlteredExpression disease BEFREE As part of the SICS, this study was conducted to evaluate the association between the incidence of acne vulgaris in SM-exposed subjects (20 years after the exposure) and serum levels of proinflammatory cytokines (IL-1α, IL-1β, IL-1Ra, IL-6, IL-8, IL-12 and RANTES) in an attempt to better understand the pathogenesis of long-term skin disorders of these individuals. 28193081 2017
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.050 Biomarker group BEFREE These results indicate that the in vivo environment regulates target cell specificity of CCL5 leading to differential cell recruitment, suggesting that antagonizing CCR5 receptor may be of therapeutic value in diseases such as acquired immuno deficiency syndrome, where CCL5/CCR5, monocytes, and Th1-type cells play a predominant role. 16778803 2006
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.050 Biomarker group BEFREE Our data suggest that a role exists for RANTES neutralization sensitivity of HIV-1 in AIDS pathogenesis. 12964118 2003
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.050 Biomarker group LHGDN RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. 17530998 2007
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.050 GeneticVariation group BEFREE The genotypic frequencies of RANTES -28G and -403A mutations did not differ significantly between LTNPs and AIDS patients. 18218038 2008
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.050 Biomarker group BEFREE This report of a non-human leukocyte antigen genetic association with HIV-1 and/or acquired immunodeficiency syndrome disease progression in an African population reveals a genetic effect different from that reported elsewhere for African Americans and may impact therapeutic strategies targeting the RANTES pathway in HIV infection. 16897666 2006
CUI: C0151332
Disease: Active tuberculosis
Active tuberculosis
0.010 GeneticVariation disease BEFREE The present study investigated the relationship between the RANTES polymorphisms (-28C/G; rs2280788, and -403G/A; rs2107538) and susceptibility to active tuberculosis (TB) in Tunisian populations. 21510799 2011
CUI: C0001306
Disease: Acute alcoholic liver disease
Acute alcoholic liver disease
0.200 Therapeutic disease RGD Optimal ratio of 18α- and 18β-glycyrrhizic acid for preventing alcoholic hepatitis in rats. 31258651 2019
CUI: C0701807
Disease: Acute anterior uveitis
Acute anterior uveitis
0.010 GeneticVariation disease BEFREE No significant association was found between AU with the CCL2 -2076 and CCL5 -403 SNPs. 19628738 2009
CUI: C0582415
Disease: Acute asthma
Acute asthma
0.010 Biomarker disease BEFREE Virus-infected subjects with acute asthma or no asthma had increased RANTES (regulated on activation, normal T cell expressed and secreted) and macrophage inflammatory protein-1alpha messenger RNAs compared with other groups. 15894599 2005
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.040 AlteredExpression disease BEFREE CCL5 levels during ACS predict a progression of preexisting CAD. 25183015 2014
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.040 GeneticVariation disease BEFREE RANTES A-403 was associated with increased ACS prevalence (OR = 1.36 [95%-CI = 1.08-1.71], p = 0.0073). 15302103 2004
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.040 Biomarker disease BEFREE The number of adherent cells and atherosclerotic plaques was counted to assess the effects of CLOCK on the progression of ACS, and adherence-associated genes, such as vascular cell adhesion molecule (VCAM)-1, C-C motif chemokine ligand 2 (CCL-2), and CCL-5. 30124738 2018
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.040 AlteredExpression disease BEFREE TC chemokine ligand 5 (CCL5) levels were not significantly (P = 0.084) elevated in patients with ACS versus patients with SAP. 31409556 2019
CUI: C0856825
Disease: Acute GVH disease
Acute GVH disease
0.020 AlteredExpression disease BEFREE We investigated the expression of aGVHD-related markers (regulated on activation normal T-cell expressed and secretes: RANTES, elafin, REG3α and ST2) and endothelial cell activation markers (soluble vascular cell adhesion molecule: sVCAM-1 and plasminogen activator inhibitor: PAI-1) in patients undergoing allogeneic HSCT. 28687251 2017
CUI: C0856825
Disease: Acute GVH disease
Acute GVH disease
0.020 Biomarker disease BEFREE However, there was no association of CCL5/CCR5 SNPs with acute GVHD. 17984846 2007
CUI: C0264714
Disease: Acute heart failure
Acute heart failure
0.010 Biomarker disease BEFREE Our results suggest the role of RANTES as a potential biomarker of cardiogenic shock and acute heart failure in the hospital phase after myocardial infarction. 24934326 2015
CUI: C0275518
Disease: Acute infectious disease
Acute infectious disease
0.020 Biomarker group BEFREE However, defects in RANTES or RANTES receptors including CCR5 can compromise immunity to acute infections in animal models and lead to more severe disease in humans infected with west Nile virus (WNV). 21814510 2011
CUI: C0275518
Disease: Acute infectious disease
Acute infectious disease
0.020 Biomarker group BEFREE Rhesus macaques were susceptible to SHIV(89.6-MIP-1alpha), SHIV(89.6-RANTES), SHIV(89.6-LTN), and nef-deleted control SHIV(89.6-dLTN) infection via the intrarectal route using standard virus doses, and intact viruses were reisolated from infected animals throughout the interval of acute infection. 12725687 2003
CUI: C0155626
Disease: Acute myocardial infarction
Acute myocardial infarction
0.020 GeneticVariation disease BEFREE We analyzed four single nucleotide polymorphisms (SNPs) of PAPP-A gene variants and seven other polymorphisms of cytokine genes that have been reported to have functional significance (RANTES G-403A, MCP1 G-2518A, CRP A2147G, CRP G-717A, AGER G557A, LTA T26A, IL-6 G-572C) for possible association with AMI in 170 unrelated AMI patients and unrelated age-matched controls, respectively. 17700210 2007
CUI: C0155626
Disease: Acute myocardial infarction
Acute myocardial infarction
0.020 AlteredExpression disease BEFREE Expression validation was performed via meta-analysis of 2 datasets, GSE22229 and GSE29111.A set of 428 DEGs in AMI were screened out, and the upregulated toll-like receptor (TLR) family genes (TLR1, TLR2, and TLR10) were enriched in wound response, immune response and inflammatory response functions, and downregulated genes (GBP5, CXCL5, GZMA, CCL5, and CCL4) were correlated with immune response. 29381915 2017
CUI: C0740766
Disease: Acute pneumonia
Acute pneumonia
0.020 AlteredExpression disease BEFREE Three kinds (PDGF-BB, IP-10, RANTES) of 27 cytokines and BPI levels were significantly elevated in patients with acute pneumonia than healthy controls. 28139879 2018
CUI: C0740766
Disease: Acute pneumonia
Acute pneumonia
0.020 Biomarker disease BEFREE Long noncoding RNA SNHG16 targets miR-146a-5p/CCL5 to regulate LPS-induced WI-38 cell apoptosis and inflammation in acute pneumonia. 31071307 2019
Acute promyelocytic leukaemia differentiation syndrome
0.010 Biomarker disease BEFREE Furthermore, serum levels of IL-8, MIP-1beta and RANTES were increased during the course of ATRA treatment in both APL patients who developed APL differentiation syndrome. 15927671 2005